Archives: Speakers

Cameron McClure, Associate Director of Clinical Trial Diversity within Global Clinical Operations, BeiGene

Cameron McClure is an Associate Director of Clinical Trial Diversity within Global Clinical Operations at BeiGene. Prior to this role he has had several leadership positions within Clinical Business Operations overseeing site contracts, budgets, payments, and a team of Business and Data Analysts.  Cameron has worked in Academia for institutions such as Stanford University and Emory University in Clinical Research Finance and began his career at Morehouse School of Medicine as a Clinical Research Coordinator. He is an agile project manager, a leader, and a visionary with a focus on process improvement through innovation.  He currently resides in Long Beach, CA with his family and enjoys traveling, music production, and learning.

Being able to strategically lead and oversee global complex clinical trials, coach and guide my team, collaborate with external and internal stakeholders, collaborate with the vendors, foresee risks and implement timely mitigation measures, continue to be agile to change management, ability to navigate through fluid/challenging situations, while being inclusive, respectful and empathetic, is what makes me a leader.

Clear decision making, effective communication, tailoring to the audience, funneling the right level of information upwards and cascading the guidance downwards, identifying process gaps and building efficiency where/as needed, keeping my team motivated and fostering a positive/growth mindset and lastly being able to wear multiple hats, with the final goal to make a positive impact to the lives of patient’s globally is what makes me a Clinical Trials Leader.

Jasminemay Barcelon, MSc, is an Analyst of Oncology and Hematology at GlobalData in the UK. Jasminemay graduated from the University of California, Los Angeles in Physiological Sciences / Pre-Medicine with three years’ experience as a physician partner in obstetrics and gynecology and gynecology oncology publishing case studies on vaginal sarcoma in pregnancy and treatment of gestational trophoblastic neoplasia. She was concurrently a lead clinical trial coordinator for four Phase III clinical trials at UCLA gaining a breadth of knowledge on clinical trial design, patient monitoring, and regulatory reporting.  She holds a Master of Science in Cancer & Molecular and Cellular Biology from the Bart’s Cancer Institute with research focused on targeting chemoresistance in high-grade serous ovarian cancer. Jasminemay is passionate about data-driven insights and developing strategies to target unmet needs in oncology.